India  

Drugs Controller General of India

Drugs Controller General of India    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   


Drugs Controller General of India (DCGI) is the head of department of the Central Drugs Standard Control Organization of the Government of India responsible for approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines, and sera in India. Drugs Controller General of India, comes under the Ministry of Health & Family Welfare. DCGI also sets standards for manufacturing, sales, import, and distribution of drugs in India.

0
shares
ShareTweetSavePostSend
 

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval [Video]

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the..

Credit: HT Digital Content     Duration: 01:40Published
Explained: India announces Covid vaccination launch date; who's first in line? [Video]

Explained: India announces Covid vaccination launch date; who's first in line?

The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had..

Credit: HT Digital Content     Duration: 01:34Published
Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains [Video]

Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains

ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine..

Credit: HT Digital Content     Duration: 04:32Published
'Who will opt for vaccine...': Congress questions approval, slams govt [Video]

'Who will opt for vaccine...': Congress questions approval, slams govt

Congress leader Manish Tewari alleged that the union government has 'politically misused pandemic in its entirety'. Tewari also slammed the Centre over the grant of approval to Bharat Biotech's Covid..

Credit: HT Digital Content     Duration: 03:25Published
'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy [Video]

'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy

Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella, addressed a virtual conference amid doubts from some quarters regarding approval of the vaccine developed by the Indian company. On..

Credit: HT Digital Content     Duration: 08:59Published
Closing Bell: Sensex closes at record-high of 48,177, Tata Steel jumps 8.2 pc [Video]

Closing Bell: Sensex closes at record-high of 48,177, Tata Steel jumps 8.2 pc

Equity benchmark indices continued their upward journey on Jan 04 with the Sensex testing 48,000 mark amid positive development on the vaccination front. Investor sentiment was lifted after the Drug..

Credit: ANI     Duration: 01:22Published
82-year-old Briton gets first dose of Oxford vaccine [Video]

82-year-old Briton gets first dose of Oxford vaccine

Britain has begun vaccinating its citizens with the AstraZeneca/Oxford vaccine against COVID-19 on January 04. The first shot was given to Brian Pinker, an 82-year-old dialysis patient, at a hospital..

Credit: ANI     Duration: 01:10Published
Won't get vaccinated for now, priority groups should be served first: Shivraj Chouhan [Video]

Won't get vaccinated for now, priority groups should be served first: Shivraj Chouhan

Madhya Pradesh Chief Minister Shivraj Singh Chouhan on January 04 said that he will not get vaccinated against COVID-19 for now, as he wants the priority groups to be served first. "I have decided that..

Credit: ANI     Duration: 01:10Published
‘Don’t know how long the Covid vaccines will be effective for’: DG-ICMR [Video]

‘Don’t know how long the Covid vaccines will be effective for’: DG-ICMR

Dr Balram Bhargava, Director General of Indian Council of Medical Research (ICMR) hailed the Covid-19 vaccines hours after Drugs Controller General of India (DCGI) gave its nod to Serum Institute of..

Credit: HT Digital Content     Duration: 02:35Published

You Might Like


Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine..
IndiaTimes - Published

Serum Institute seeks DCGI nod for clinical trials of Covid-19 vaccine Covavax


IndiaTimes - Published

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-March

Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new..
IndiaTimes - Published

From abroad, Rahul directing Cong rumour-mongering: BJP

I​ntensifying attack on Congress for questioning the DCGI’s approval to Covid vaccines, BJP on Monday said Rahul Gandhi, while on a vacation abroad, choreographed rumour-mongering by enlisting his..
IndiaTimes - Published

DCGI allows Bharat Biotech to conduct vaccine trials on children above 12

Covaxin has already been used on children above 12 in phase I and II trials and has been found safe.
DNA - Published

Like Putin and Joe Biden, PM Modi should also get the first vaccine shot, says Cong leader

The DCGI on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
DNA - Published

Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine


IndiaTimes - Published

Great milestone in India's scientific capability: Bharat Biotech after DCGI approval to Covaxin

The Hyderabad-based vaccine maker expressed its delight after DCGI granted permission for emergency use of its Covid-19 vaccine.
DNA - Published

Covid-19 vaccines 110% safe, impotency rumours complete nonsense: DCGI

As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the Covid-19 vaccines regarding impotency, rubbishing..
IndiaTimes - Published

'Watershed moment in India's battle against COVID': Politicos react over emergency use approval

DCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
DNA - Published

'Proud that two made in India vaccines given emergency use approval': PM Modi after DCGI nod

PM Modi also extended his gratitude to doctors, medical staff, scientists, sanitation workers and all 'Corona warriors' for the outstanding work.
DNA - Published

Covishield COVID-19 vaccine ready to roll out in coming weeks: SII's Adar Poonawalla

Poonawalla's remarks came soon after DCGI approved Serum Institute's 'Covishield' vaccine for restricted emergency use in India.
DNA - Published

DCGI approves Oxford's Covishield and Bharat Biotech's Covaxin vaccines for restricted emergency use


IndiaTimes - Published

BREAKING: DCGI grants approval to Serum Institute, Bharat Biotech's COVID-19 vaccines

The approval comes after the clearances from the Subject Expert Committee (SEC).
DNA - Published

Bharat Biotech’s Covaxin too gets nod for emergency use

India's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
IndiaTimes - Published

Covaxin vaccine: DCGI panel to meet Bharat Biotech officials shortly


IndiaTimes - Published

Happy New Year: Expert panel clears Oxford vaccine for India

India moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending emergency-use authorisation (EUA) for Serum..
IndiaTimes - Published

Probably we will have a very happy New Year: DCGI on Covid-19 vaccine

India is likely to have a Covid-19 vaccine in the New Year, Drug Controller General of India V G Somani hinted on Thursday. Speaking at a webinar, Somani said the most important thing is that the..
IndiaTimes - Published

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an..
IndiaTimes - Published

COVID-19 vaccine: Serum Institute seeks emergency use authorisation for Covishield in India

The Serum Institute of India is the second company with a COVID-19 vaccine candidate to seek emergency use authorisation from the DCGI in India.
DNA - Published Also reported by •IndiaTimes

Pfizer becomes first pharma company in India to seek emergency use nod for its Covid-19 vaccine

Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country. It is to..
IndiaTimes - Published

DCGI finds no link between Covid vaccine shot and 'adverse' reaction in Chennai volunteer during trial: Sources


IndiaTimes - Published

COVID-19 vaccine: Covidshield may be ready for rollout by Dec, says Serum Institute CEO

Covidshield has shown promising results during trials, but a lot depends on the approvals coming through from the Drugs Controller General Of India.
DNA - Published

ICMR issues advisory on CRISPR technology-based SARS CoV-2 test

The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General of India for Covid-19 detection. As..
IndiaTimes - Published

Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers

The Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on..
IndiaTimes - Published

Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India

After the Indian drug regulator turned down Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct direct Phase-3 human trials for the Russian Covid-19 vaccine Sputnik V, the company..
IndiaTimes - Published

Bharat Biotech asked to submit complete phase 2 data of its Covid-19 vaccine before phase 3 trial

Bharat Biotech, which had sought DCGI's nod for conducting phase-3 clinical trials of its Covid-19 vaccine candidate, has been asked to submit complete safety and immunogenicity data of the ongoing..
IndiaTimes - Published

DCGI nod to Phase-1 human trials of 'antisera' with potential to treat Covid-19

The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a..
IndiaTimes - Published

Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks

On September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
DNA - Published

Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nod

The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
DNA - Published

Serum Institute to resume vaccine trials after DCGI nod


IndiaTimes - Published

Will resume Covid-19 vaccine trials after DCGI nod: Serum Institute


IndiaTimes - Published

DCGI orders Serum Institute of India to suspend recruitment for Oxford Covid-19 vaccine trials


IndiaTimes - Published

Serum pauses trials of Oxford vaccine after DCGI’s notice


IndiaTimes - Published

Serum Institute gets DCGI notice over Oxford Covid-19 vaccine trial suspension by AstraZeneca abroad

The central drug regulator has issued a show-cause notice to Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine..
IndiaTimes - Published

Covid-19: Subject Expert Committee seeks DCGI's nod to use hepatitis injection for phase III clinical trial


IndiaTimes - Published Also reported by •DNA

COVID-19 medicine: Lupin launches Favipiravir in India at Rs 49 per tablet

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use on COVID-19 patients as a potential treatment
DNA - Published

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
IndiaTimes - Published

DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccine

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford University's Covid-19 vaccine candidate in..
IndiaTimes - Published

Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India

DCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.
DNA - Published

Covid-19: Health ministry decides not to put Itolizumab in national treatment protocol

Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab drug for restricted emergency use on moderate to severe Covid-19 patients, the Union health ministry has decided..
IndiaTimes - Published

DCGI seeks clarification from Glenmark on its anti-viral favipiravir for use on Covid-19 patients


IndiaTimes - Published

India gets its first desi pneumonia vaccine

India has got its first locally developed pneumonia vaccine, reducing its dependence on imports for immunisation against a disease that contributes to most deaths in children under five years of age...
IndiaTimes - Published

Govt OKs use of skin ailment drug for Covid patients

Drug regulator Drugs Controller General of India (DCGI) has approved Itolizumab, for restricted emergency use on Covid-19 patients with moderate to severe acute respiratory distress. Itolizumab is..
IndiaTimes - Published

Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

After Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the Drugs Controller General of India (DCGI) on..
IndiaTimes - Published

Hyderabad company develops India’s first DCGI-approved vaccine candidate, gets nod for human trials


IndiaTimes - Published


 Page 1  〉